Supplemental Oxygen

Drug	Drug Name	Drug Description
DB14761	Remdesivir	A nucleoside analog used to treat RNA virus infections including COVID-19.
DB06273	Tocilizumab	An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA).

Drug	Drug Name	Target	Type
DB14761	Remdesivir	Replicase polyprotein 1ab	target
DB14761	Remdesivir	RNA-directed RNA polymerase L	target
DB14761	Remdesivir	Cytochrome P450 2C8	enzyme
DB14761	Remdesivir	Cytochrome P450 2D6	enzyme
DB14761	Remdesivir	Cytochrome P450 3A4	enzyme
DB14761	Remdesivir	Solute carrier organic anion transporter family member 1B1	transporter
DB14761	Remdesivir	P-glycoprotein 1	transporter
DB14761	Remdesivir	Solute carrier organic anion transporter family member 1B3	transporter
DB14761	Remdesivir	Bile salt export pump	transporter
DB14761	Remdesivir	Multidrug resistance-associated protein 4	transporter
DB14761	Remdesivir	Sodium/bile acid cotransporter	transporter
DB14761	Remdesivir	Liver carboxylesterase 1	enzyme
DB14761	Remdesivir	Lysosomal protective protein	enzyme
DB14761	Remdesivir	Replicase polyprotein 1ab	target
DB14761	Remdesivir	Replicase polyprotein 1ab	target
DB14761	Remdesivir	Multidrug and toxin extrusion protein 1	transporter
DB06273	Tocilizumab	Interleukin-6 receptor subunit alpha	target
DB06273	Tocilizumab	Cytochrome P450 3A4	enzyme

Drug	Drug Name	Phase	Status	Count